Investigation of interaction between human hemoglobin A0 and platinum anticancer drugs by capillary isoelectric focusing with whole column imaging detection

Journal of Separation Science

Volumn 31, Issue 10, 2008, Pages 1803-1809

  Lemma, Tibebe ^a   Mandal, Rupasri ^b   Li, Xing Fang ^b   Pawliszyn, Janusz ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Capillary isoelectric focusing; Human hemoglobin A0; Platinum anticancer drugs; Whole column imaging detection

Indexed keywords

AMINES; CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; DRUG INTERACTIONS; FLOW INTERACTIONS; HEMOGLOBIN;

ANTI CANCER DRUGS; CISPLATIN (CDDP); CYCLOHEXANEDIAMINE; HUMAN HEMOGLOBIN; OXALIPLATIN; PLATINUM (II); WHOLE COLUMN IMAGING DETECTION;

PLATINUM;

ANTINEOPLASTIC AGENT; CISPLATIN; HEMOGLOBIN A; OXALIPLATIN; PLATINUM DERIVATIVE;

ANALYTIC METHOD; ARTICLE; CAPILLARY ISOELECTRIC FOCUSING; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG PROTEIN BINDING; IMAGING; INCUBATION TEMPERATURE; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN STABILITY; VALIDITY;

ANTINEOPLASTIC AGENTS; CHEMISTRY, ANALYTICAL; CISPLATIN; ELECTROPHORESIS, CAPILLARY; HEMOGLOBIN A; HUMANS; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; MOLECULAR CONFORMATION; ORGANOPLATINUM COMPOUNDS; PROTEIN BINDING; TEMPERATURE; TIME FACTORS;

SPIROPLASMA PHAGE 4;

EID: 46249124468     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.200700418     Document Type: Article

References (42)

1. Cvitkovic, E., Semin. Oncol. 1998, 25, 1-3.
2. Graham, M. A., Lockwood, G. F., Greenslade, D., Brienza, S., Bayssas, M., Gamelin, E., Clin. Cancer Res. 2000, 6, 1205-1218.
3. Cvitkovic, E., Br. J. Cancer 1998, 77, 8-11.
4. Dunn, T. A., Schmoll, H. J., Gruenwald, V., Bokemeyer, C., Casper, J., Investig. New Drugs 1997, 15, 109-114.
5. Soulie, P., Bensmaine, A., Garrino, C., Chollet, P., Brain, E., Fereres, M., Jasmin, C., Musset, M., Misset, J. L., Cvitkovic, E., Eur. J. Cancer 1997, 33, 1400-1406.
6. Gamelin, E., Le Bouil, A., Boisdron-Celle, M., Turcant, A., Delva, R., Cailleux, A., Krikorian, A., Brienza, S., Cvitkovic, E., Robert, J., Larra, F., Allain, P., Clin. Cancer Res. 1997, 3, 891-899.
7. O'Dwyer, P. J., Stevenson, J. P., Johnson, S. W., Drugs 2000, 59, 19-27.
8. Louvet, C., Andre, T., Tigaud, J. M., Gamelin, E., Douillard, J. Y., Brunet, R., Francois, E., Jacob, J. H., Levoir, D., Taamma, A., Rougier, P., Cvitkovic, E., de Gramont, A., J. Clin. Oncol. 2002, 20, 4543-4548.
9. Kern, W., Beckett, B., Lang, N., Stemmler, J., Beykirch, M., Stein, J., Goecke, E., Waggershauser, T., Braess, J., Schalhorn, A., Hiddemann, W., Ann. Oncol. 2001, 12, 599-603.
10. Eastman, A., Biochemistry 1982, 21, 6732-6736.
11. Jamieson, E. R., Lippard, S. J., Chem. Rev. 1999, 99, 2467-2498.
12. Go, R. S., Adjei, A. A. J. Clin. Oncol. 1999, 17, 409-422.
13. Kung, A., Strickmann, D. B., Galanski, M., Keppler, B. K., J. Inorg. Biochem. 2001, 86, 691-698.
14. Gullo, J. J., Litterst, C. L., Maguire, P. J., Sikic, B. I., Hoth, D. F., Woolley, P. V., Cancer Chemother. Pharmacol. 1980, 5, 21-26.
15. Boisdron-Celle, M., Lebouil, A., Allain, P., Gamelin, E., Bull. Cancer 2001, 88, S14-S19.
16. Pendyala, L., Creaven, P.J., Cancer Res. 1993, 53, 5970-5976.
17. Rai, D. K., Landin, B., Alvelius, G., Griffiths, W. J., Anal. Chem. 2002, 74, 2097-2102.
18. Espinosa, E., Feliu, J., Zamora, P., Gonzalez Baron, M., Sanchez, J. J., Ordon ez, A., Espinosa, J., Lung Cancer 1995, 12, 67-76.
19. Mandal, R., Kalke, R., Li, X.-F., Chem. Res. Toxicol. 2004, 17, 1391-1397.
20. Timerbaev Andrei, R., Hartinger Christian, G., Aleksenko Svetlana, S., Keppler Bernhard, K., Chem. Rev. 2006, 106, 2224-2248.
21. Gibson, D., Costello, C. E., Eur. Mass Spectrom. 1999, 5, 501-510.
22. Peleg-Shulman, T., Najajreh, Y., Gibson, D., J. Inorg. Biochem. 2002, 91, 306-311.
23. Najajreh, Y., Peleg-Shulman, T., Moshel, O., Farrell, N., Gibson, D., J. Biol. Inorg. Chem. 2003, 8, 167-175.
24. Mandal, R., Kalke, R., Li, X.-F., Rapid Commun. Mass Spectrom. 2003, 17, 2748-2754.
25. Mandal, R., Teixeira, C., Li, X.-F., Analyst 2003, 128, 629-634.
26. Hagrman, D., Goodisman, J., Dabrowiak, J. C., Souid, A.-K., Drug Metabol. Dispos. 2003, 31, 916-923.
27. Mandal, R., Jiang, G., Li, X.-F., Appl. Organomet. Chem. 2003, 17, 675-681.
28. Carr, J. L., Tingle, M. D., McKeage, M. J., Cancer Chemother. Pharmacol. 2002, 50, 9-15.
29. Timerbaev, A. R., Aleksenko, S. S., Polec-Pawlak, K., Ruzik, R., Semenova, O., Hartinger, C. G., Oszwaldowski, S., Galanski, M., Jarosz, M., Keppler, B. K., Electrophoresis 2004, 25, 1988-1995.
30. Rudnev, A. V., Aleksenko, S. S., Semenova, O., Hartinger, C. G., Timerbaev, A. R., Keppler, B. K., J. Sep. Sci. 2005, 28, 121-127.
31. Warnecke, A., Fichtner, I., Garmann, D., Jaehde, U., Kratz, F., Bioconjug. Chem. 2004, 15, 1349-1359.
32. Hjerten, S., Zhu, M. D., J. Chromatogr. 1985, 346, 265-270.
33. Liu, Z., Pawliszyn, J., Anal. Chem. 2003, 75, 4887-4894.
34. Bo, T., Pawliszyn, J., Anal. Chim. Acta 2006, 559, 1-8.
35. Reedijk, J., Chem. Commun. 1996, 801-806.
36. Liu, Z., Drabovich, A. P., Krylov, S. N., Pawliszyn, J., Anal. Chem. 2007, 79, 1097-1100.
37. Bo, T., Pawliszyn, J., J. Chromatogr. A 2006, 1105, 25-32.
38. Bo, T., Pawliszyn, J., J. Sep. Sci. 2006, 29, 1018-1025.
39. Bo, T., Pawliszyn, J., Anal. Biochem. 2006, 350, 91-98.
40. Bo, T., Pawliszyn, J., Electrophoresis 2006, 27, 852-858.
41. Liu, Z., Lemma, T., Pawliszyn, J., J. Proteome Res. 2006, 5, 1246-1251.
42. Yang, X.-X., Hu, Z.-P., Chan, S. Y., Zhou, S.-F., Clin. Chim. Acta 2006, 365, 9-29.